Contents/Index File

1.115 503


or Brief Communication.STYLE: Use appropriate subheadings throughout the body of the text, such as Methods, Results, and Discussion. Tables, figures, and references should be mentioned in numerical order throughout manuscript. Abbreviations are permitted, but no more than 3 per manuscript, and then they must be used on every page of the manuscript after they are initially spelled out (followed by the abbreviation) in both abstract and introduction. Abbreviations are usually limited to terms in the manuscript’s title. Use generic names of drugs. Do not spell out any number, including those less than 10, except when used for opening a sentence, but try not to begin sentences with numbers. Use symbols for less than (<), greater than (>) and percent (%). Indent paragraphs except the first one in both abstract and introduction.Consult the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, published in N Engl J Med 1991; 324: 424-428. TRADE NAMES Non-proprietary (generic) names of products should be used. If a brand name for a drug is used, the British or International non-proprietary (approved) name should be given. The source of any new or experimental preparation should also be given. REFERENCES: References should be limited to those relating directly to the content of the paper. List all authors, year, volume, and inclusive pages for all journal references, and specific page numbers for all book references as shown below. Do not use periods after authors’ initials or after abbreviations for titles of journals. Check Index Medicus or N Engl J Med 1991;324:424-8 as cited above for journal titles and abbreviations. Personal communications and unpublished observations do not constitute references, but may be mentioned within the text. Please note that all authors should be listed when six or less; when seven or more, list only the first three and add et al. Please do not use the footnote or endnote functions in your word processing program. Journal: Vikse BE, Aasard K, Bostad L, Iversen BM. Clinical prognostic factors in biopsy-proven benign nephrosclerosis. Nephrol Dial Transplant 2003;18:517-23

Full Text: